ARCHIVES

Bristol-Myers, IVAX submit Competing Application for Paclitaxel Use In KS

This article is from The Cancer Letter archive.

Vol. 23 No. 15 | April 18, 1997

Download PDF Visit The Full Archive

Related Articles

CCOP Wins Vote Of Confidence From NCI Advisors

November 12, 2010

Sponsors Withdraw Indications for Iressa, Celebrex

February 11, 2011

Executive Branch Should Improve Science Pay, NAS Says

July 16, 1993

Tobacco Control and Prevention Saved 795,000 Lives Between 1975-2000, Study Shows

March 30, 2012

NCI Decides To Accept NCAB Recommendation, Award Organ Systems Coordinating Center to Roswell Park

July 6, 1984

Revlimid Maintenance Therapy Delayed Progression by 90%

May 27, 2011